Stem Cell Transplant Trial Enrolls First Patient in Minnesota A clinical trial investigating patient-derived stem cell transplants for the treatment of people with severe relapsing forms of multiple sclerosis (MS) has enrolled a patient in Minnesota. Read more...
Potential for Stem Cells to Repair Myelin Focus of University Toronto Team Teams of scientists at the University of Toronto are sharing a nearly CA$21 million (about $16.36 million) award into research that might lead to self-repair treatments for multiple sclerosis (MS) and other neurological disorders, the university announced in
How Does the Immune System Keep Tabs on the Brain? Alzheimer’s disease, multiple sclerosis, autism, schizophrenia and many other neurological and psychiatric conditions have been linked to inflammation in the brain. There’s growing evidence that immune cells and molecules play a key role in normal brain development and function as
Aubagio Slows Grey Matter, Whole Brain Atrophy in CIS, Study Finds Studied for the first time, Aubagio (teriflunomide) slowed the loss of cortical grey matter and whole-brain volume in people with clinically isolated syndrome (CIS) during two years of therapy, a study found. The treatment was especially effective in those
Research Reveals Another Possible Epstein-Barr Virus Link to MS Over the years, many studies have looked at a possible EBV-MS connection. One of the latest was published earlier this year, with researchers reporting that the interaction between certain genes and the virus is “consistent with an EBV susceptibility signature contributing to